0000000000879720

AUTHOR

Susan Dababou

showing 2 related works from this author

5th International Symposium on Focused Ultrasound

2016

Introduction Breast fibroadenomata (FAD) are benign lesions which occur in about 10 % of all women. Diagnosis is made by triple assessment (physical examination, imaging and/or histopathology/cytology). For a definitive diagnosis of FAD, the treatment is conservative unless the patient is symptomatic. For symptomatic patients, the lumps can be surgically excised or removed interventionally by vacuum-assisted mammotomy (VAM). Ablative techniques like high-intensity focused ultrasound (HIFU), cryo-ablation and laser ablation have also been used for the treatment of FAD, providing a minimally invasive treatment without scarring or poor cosmesis. This review summarises current trials using mini…

lcsh:Medical physics. Medical radiology. Nuclear medicineFibroadenomataCryo-ablationHigh-intensity focused ultrasoundAblative techniqueslcsh:R895-920ReviewMeeting AbstractsLaser ablationJournal of Therapeutic Ultrasound
researchProduct

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.

2022

Total hysterectomy and bilateral adnexectomy is the standard treatment for atypical endometrial hyperplasia and early-stage endometrial cancer. However, the recommended surgical treatment precludes future pregnancy when these conditions are diagnosed in women in their fertile age. In these patients, fertility-sparing treatment may be feasible if the desire for childbearing is consistent and specific conditions are present. This review summarizes the available evidence on fertility-sparing management for atypical endometrial hyperplasia and early-stage endometrial cancer. Historically, oral progestins have been the mainstay of conservative management for atypical endometrial hyperplasia and …

fertility-sparing treatmentFertility PreservationGeneral MedicineConservative TreatmentSettore MED/40 - Ginecologia E OstetriciaMetforminEndometrial NeoplasmsProgestinGonadotropin-Releasing HormoneTreatment OutcomeRetrospective StudiePregnancyendometrial cancerEndometrial HyperplasiaHumansEndometrial NeoplasmFemaleendometrial atypical hyperplasiaProgestinsHumanRetrospective StudiesMedicina (Kaunas, Lithuania)
researchProduct